Monash Ivf Group Ltd (MVF.AX) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · Australia · ISIN AU000000MVF3
Monash Ivf Group Ltd financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 271.92 m AUD | 269.46 m AUD |
| Gross profit | 90.31 m AUD | 61.93 m AUD |
| Operating income | 43.41 m AUD | 20.68 m AUD |
| EBIT | 44.17 m AUD | 20.68 m AUD |
| Net income | 25.01 m AUD | 7.43 m AUD |
| Diluted EPS – continuing operations | 0.06 AUD | 0.02 AUD |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Monash Ivf Group Ltd
Monash IVF Group Limited engages in the provision of assisted reproductive genetic and specialist women imaging services in Australia and Southeast Asia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. The company also provides tertiary level prenatal diagnostic, ultrasound, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Cremorne, Australia.
More stocks
- Iones Co. Ltd (114810.KQ)
- Chicago Atlantic BDC, Inc. (LIEN)
- Young Optics Inc (3504.TW)
- Grupo Gicsa S.A. de C.V (GICSAB.MX)
- ICTS International N.V (ICTSF)
- Cerrado Gold Corp (CERT.V)
- Neo Corporate Pcl (NEO.BK)
- Steyr Motors AG (4X0.VI)
- ALTEO Energiaszolgaltato Nyrt. (ALTEO.BD)
- technotrans (TTR1.DE)
- Highlight Tech (6208.TWO)
- Nishoku Technology Inc (3679.TW)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.